Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organon & Co. (NY: OGN )

18.00 +0.02 (+0.11%)
Official Closing Price Updated: 4:10 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Organon & Co.

< Previous 1 2 3 Next >
Organon Declares Paid Time Off for All Employees on International Women’s Day; Employees to Focus on Their Own Health in Recognition of Growing Women’s Health Inequity
From Organon & Co.
Via Business Wire
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 17, 2022
From Organon & Co.
Via Business Wire
FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate
From Organon & Co.
Via Business Wire
Organon To Present at the 40th Annual J.P. Morgan Healthcare Virtual Conference
From Organon & Co.
Via Business Wire
Organon Completes Acquisition of Forendo Pharma
From Organon & Co.
Via Business Wire
Organon To Present at the Evercore ISI 4th Annual HealthCONx Conference
From Organon & Co.
Via Business Wire
Organon Reports Results for the Third Quarter Ended September 30, 2021
From Organon & Co.
Via Business Wire
Organon to Acquire Forendo Pharma
From Organon & Co.
Via Business Wire
Organon To Report Third Quarter Results and Host Conference Call on November 11, 2021
From Organon & Co.
Via Business Wire
Organon Launches New Fertility Journey Website as Part of Ongoing Commitment to Help Address the Needs of Women
From Organon & Co.
Via Business Wire
Organon Receives FDA Clearance for Technological Updates to the Jada® System, a Medical Device Intended to Control Postpartum Hemorrhage
From Organon & Co.
Via Business Wire
Organon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy
From Organon & Co.
Via Business Wire
Organon To Present at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference
From Organon & Co.
Via Business Wire
Organon To Present at Citi’s 16th Annual BioPharma Virtual Conference
From Organon & Co.
Via Business Wire
Organon Reports Results for the Second Quarter Ended June 30, 2021 and Announces Inaugural Dividend
From Organon & Co.
Via Business Wire
Organon and ObsEva Enter Global License Agreement to Develop and Commercialize Ebopiprant (OBE022), an Investigational Agent Being Evaluated as a First-in-Class Treatment for Preterm Labor
From Organon
Via Business Wire
Organon To Report Fiscal Q2 Results and Host Conference Call on August 12, 2021
From Organon & Co.
Via Business Wire
Organon Recommends Stockholders Reject Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
From Organon & Co.
Via Business Wire
Organon Announces Filing of Form 10-Q for the Quarter Ended March 31, 2021
From Organon & Co.
Via Business Wire
Organon Completes Acquisition of Alydia Health – A Medical Device Company Focused on Postpartum Hemorrhage
From Organon & Co.
Via Business Wire
ADDING MULTIMEDIA Organon Launches as New Global Women’s Health Company
From Organon
Via Business Wire
Organon Launches as New Global Women’s Health Company
From Organon & Co.
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.